Implementation of strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in U.S. hospitals

Infection Control and Hospital Epidemiology

Volumn 26, Issue 1, 2005, Pages 21-30

  Ward, Marcia M ^a,c   Diekema, Daniel J ^b,c   Yankey, Jon W ^c   Vaughn, Thomas E ^a,c   BootsMiller, Bonnie J ^b,c   Pendergast, Jane F ^a   Doebbeling, Bradley N ^d,e,f  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e REGENSTRIEF INSTITUTE   (United States)

^f INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; EDUCATION; HEALTH CARE QUALITY; HOSPITAL; HOSPITAL MANAGEMENT; INFECTION CONTROL; LEADERSHIP; MANAGEMENT; MULTIVARIATE ANALYSIS; NATIONAL FOUNDATION FOR INFECTIOUS DISEASES; ORGANIZATION; PUBLIC HEALTH SERVICE; REVIEW;

ANALYSIS OF VARIANCE; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HOSPITALS; HUMANS; INFECTION CONTROL; SAFETY MANAGEMENT; UNITED STATES;

EID: 12144255484     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502483     Document Type: Review

References (39)

1. Shlaes DM, Gerding DN, John JF, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584-599.
2. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control, the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 1996;275:234-240.
3. Cohen ML. Epidemiology of drug resistance: implications for a postantimicrobial era. Science 1992;257:1050-1055.
4. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin: United States, 2002. MMWR 2002;51:565-566.
5. Goldmann DA, Huskins WC. Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. Clin Infect Dis 1997;24(suppl 1):S139-S145.
6. Jarvis WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problem. Infect Control Hosp Epidemiol 1996;17:490-495.
7. McGowan JE Jr, Tenover FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am 1997;11:297-311.
8. Gaynes R. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am 1997;11:757-765.
9. Shay DK, Goldmann DA, Jarvis WR. Reducing the spread of antimicrobial-resistant microorganisms. Pediatr Clin North Am 1995;42:703-716.
10. Boyce JM. Vancomycin-resistant enterococcus: detection, epidemiology, and control measures. Infect Dis Clin North Am 1997;11:367-384.
11. Casewell MW. New threats to the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1995;30(suppl):465-471.
12. The Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995;23:878-894.
13. Garner JS. Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention: guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53-80.
14. Duncan RA. Controlling use of antimicrobial agents. Infect Control Hosp Epidemiol 1997;18:260-266.
15. Martone WJ. Spread of vancomycin-resistant enterococcci: why did it happen in the United States? Infect Control Hosp Epidemiol 1998;19:539-545.
16. Diekema DJ, Pfaller MA, Jones RN, et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis 1999;29:595-607.
17. Wakefield DS, Pfaller M, Massanari RM, Hammons GT. Variation in methicillin-resistant Staphylococcus aureus occurrence by geographic location and hospital characteristics. Infect Control 1987;8:151-157.
18. Dillman DA. Mail and Internet Surveys: The Tailored Design Method, ed. 2. New York: John Wiley and Sons; 2000.
19. Beekmann SE, Vaughn TE, McCoy KD, et al. Hospital bloodborne pathogens programs: program characteristics and blood and body fluid exposure rates. Infect Control Hosp Epidemiol 2001;22:73-82.
20. McCoy KD, Beekmann SE, Ferguson KJ, et al. Monitoring adherence to standard precautions. Am J Infect Control 2001;29:24-31.
21. Vaughn TE, Ward MM, Doebbeling BN, Uden-Holman T, Clarke WT, Woolson RE. Organizational and provider characteristics fostering smoking cessation clinical guideline adherence: an empirical look. Journal of Ambulatory Care Management 2002;25:17-31.
22. Vaughn TE, McCoy K, BootsMiller BJ, et al. Organizational predictors of adherence to ambulatory care screening guidelines. Med Care 2002;40:1172-1185.
23. Harrell FE Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer-Verlag; 2001.
24. Harrell FE, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modeling strategies for improved prognostic prediction. Stat Med 1984;3:143-152.
25. Lawton RM, Fridkin SK, Gaynes RP, McGowan JE Jr, Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Hospitals. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Infect Control Hosp Epidemiol 2000;21:256-259.
26. Lundstrom T, Pugliese G, Bartley J, Cox J, Guither C. Organizational and environmental factors that affect worker health and safety and patient outcomes. Am J Infect Control 2002;30:93-106.
27. Solberg LI. Guideline implementation: what the literature doesn't tell us. Journal of Quality Improvement 2000;26:525-537.
28. Solberg LI, Brekke ML, Fazio CJ, et al. Lessons from experienced guideline implementers: attend to many factors and use multiple strategies. Journal of Quality Improvement 2000;26:171-188.
29. Institute of Medicine. Crossing the Quality Chasm. Washington, DC: National Academy Press; 2004:137-140.
30. Lammers JC, Cretin S, Gilman S, Calingo E. Total quality management in hospitals. Med Care 1996;34:463-478.
31. Gershon RRM, Karkashian CD, Vlahov D, et al. Compliance with universal precautions in correctional health care facilities. Journal of Occupational and Environmental Medicine 1999;41:181-189.
32. Grosch JW, Gershon RRM, Murphy LP, DeJoy DM. Safety climate dimensions associated with occupational exposure to blood-borne pathogens in nurses. Am J Ind Med 1999(suppl 1):122-124.
33. Doebbeling BN, Vaughn TE, Woolson RF, et al. Benchmarking Veterans Affairs medical centers in the delivery of preventive health services. Med Care 2002;40:540-554.
34. Drachman DA. Benchmarking patient satisfaction at academic health centers. Journal of Quality Improvement 1996;22:359-367.
35. Weissman NW, Allison JJ, Kiefe CI, et al. Achievable benchmarks of care: the ABCs of benchmarking. J Eval Clin Pract 1999:5:269-281.
36. O'Neal PV, Oxcan YA, Ma Y. Benchmarking mechanical ventilation services in teaching hospitals. J Med Syst 2002;26:227-240.
37. Ellis J. Sharing the evidence: clinical practice benchmarking to improve continuously the quality of care. J Adv Nursing 2000;32:215-225.
38. Grabert M, Schweiggert F, Holl RW. A framework for diabetes documentation and quality management in German: 10 years of experience with DPV. Comput Methods Programs Biomed 2002;69:115-121.
39. Nora JJ, Diekema DJ, Vaughn TE, et al. Antimicrobial resistance (AMR) in epidemiologically-important organisms in U.S. hospitals. Presented at the 9th Annual Meeting of the Infectious Diseases Society of America; October 25-28, 2001; San Francisco, CA.